Impaired activation of the supplementary motor area in Parkinson's disease is reversed when akinesia is treated with apomorphine.

Impaired activation of the supplementary motor area in Parkinson's disease is reversed when akinesia is treated with apomorphine.

Using positron emission tomography (PET) we previously showed that activation of the putamen, supplementary motor area, and cingulate cortex is impaired in patients with Parkinson's disease (PD) when they are off treatment and perform volitional motor tasks. Evidence suggests that these areas a...

Szczegółowa specyfikacja

Opis bibliograficzny
Główni autorzy:	Jenkins, I, Fernandez, W, Playford, E, Lees, A, Frackowiak, R, Passingham, R, Brooks, D
Format:	Journal article
Język:	English
Wydane:	1992

Podobne zapisy

Impaired activation of frontal areas during movement in Parkinson's disease: a PET study.
od: Playford, E, i wsp.
Wydane: (1993)

Impaired mesial frontal and putamen activation in Parkinson's disease: a positron emission tomography study.
od: Playford, E, i wsp.
Wydane: (1992)

Reversal of akinesia in experimental parkinsonism by GABA antagonist microinjections in the pedunculopontine nucleus.
od: Nandi, D, i wsp.
Wydane: (2002)

Reversal of akinesia in experimental parkinsonism by GABA antagonist microinjections in the pedunculopontine nucleus
od: Nandi, D, i wsp.
Wydane: (2002)

Apomorphine in the treatment of Parkinson's disease: a review
od: Renata Ramina Pessoa, i wsp.

Apomorphine in the Treatment of Parkinson’s Disease
od: Serhat Özkan
Wydane: (2021-12-01)

Apomorphine in Parkinson's disease—The questions raised
od: Rajinder K Dhamija, i wsp.
Wydane: (2020-01-01)

IMPAIRED ACTIVATION OF MESIAL FRONTAL-CORTEX DURING SELF-PACED MOVEMENTS IN PARKINSONS-DISEASE
od: Jenkins, I, i wsp.
Wydane: (1994)

Akinesia, motor oscillations and the pedunculopontine nucleus in rats and men.
od: Stein, J
Wydane: (2009)

Continuous subcutaneous apomorphine monotherapy in Parkinson’s disease
od: Ewa Papuć, i wsp.
Wydane: (2019-03-01)

Intermittent Subcutaneous Injections of Apomorphine in Parkinson’s Disease
od: Mustafa Ceylan, i wsp.
Wydane: (2022-12-01)

Functional specialization of the supplementary motor area in monkeys and humans.
od: Passingham, R
Wydane: (1996)

Impact of deep brain stimulation on upper limb akinesia in Parkinson's disease.
od: Brown, R, i wsp.
Wydane: (1999)

Zonisamide Enhances Motor Effects of Levodopa, Not of Apomorphine, in a Rat Model of Parkinson’s Disease
od: Haruo Nishijima, i wsp.
Wydane: (2018-01-01)

THE LEARNING OF MOTOR SEQUENCES - A PET STUDY
od: Jenkins, I, i wsp.
Wydane: (1992)

Apomorphine and Levodopa Infusion Therapies for Advanced Parkinson’s Disease
od: Angelo Antonini
Wydane: (2009-05-01)

Motor sequence learning: a study with positron emission tomography.
od: Jenkins, I, i wsp.
Wydane: (1994)

A PET STUDY OF THE FUNCTIONAL-ANATOMY OF MOTOR SEQUENCE LEARNING
od: Jenkins, I, i wsp.
Wydane: (1993)

Functional imaging correlates of akinesia in Parkinson's disease: Still open issues
od: Charlotte Spay, i wsp.
Wydane: (2019-01-01)

SUPPLEMENTARY MOTOR CORTEX AND SELF-INITIATED MOVEMENT
od: Passingham, R, i wsp.
Wydane: (1989)

Fetal Akinesia-Hipokinesia Sindrome
od: Alberto Vélez van Meerbeke
Wydane: (2005-06-01)

Spinal cord stimulation failed to relieve akinesia or restore locomotion in Parkinson disease.
od: Thevathasan, W, i wsp.
Wydane: (2010)

The Supplementary Motor Complex in Parkinson’s Disease
od: Shervin Rahimpour, i wsp.
Wydane: (2022-01-01)

Investigation of apomorphine during sleep in Parkinson’s: Improvement in UPDRS Scores
od: Miguel A. Pieroni
Wydane: (2019-12-01)

Lateral pallidotomy exacerbates akinesia in the Parkinsonian patient.
od: Munro-Davies, L, i wsp.
Wydane: (1999)

The effect of the dopamine agonist, apomorphine, on regional cerebral blood flow in normal volunteers.
od: Grasby, P, i wsp.
Wydane: (1993)

Challenges and trends in apomorphine drug delivery systems for the treatment of Parkinson's disease
od: Nrupa Borkar, i wsp.
Wydane: (2018-11-01)

Subcutaneous apomorphine in advanced Parkinson’s disease and its use in Indian population
od: Vinod Metta, i wsp.
Wydane: (2020-01-01)

Clinical trial evaluating apomorphine oromucosal solution in Parkinson's disease patients
od: Eva Thijssen, i wsp.
Wydane: (2024-05-01)

Apomorphine effects on the hippocampus
od: Luis Enrique Arroyo-Garcia, i wsp.
Wydane: (2018-01-01)

Inhibitory Effect of Apomorphine on Focal and Nonfocal Plasticity in the Human Motor Cortex
od: Shane M. Fresnoza, i wsp.
Wydane: (2021-05-01)

Looking beyond the fog—apomorphine demystified
od: L K Prashanth, i wsp.
Wydane: (2020-01-01)

The prevalence of impulsive compulsive behaviors in patients treated with apomorphine infusion: a retrospective analysis
od: Pedro Barbosa, i wsp.
Wydane: (2021-11-01)

The functions of the supplementary motor area. Summary of a workshop.
od: Marsden, C, i wsp.
Wydane: (1996)

Anatomy of motor learning. II. Subcortical structures and learning by trial and error.
od: Jueptner, M, i wsp.
Wydane: (1997)

POSITRON EMISSION TOMOGRAPHY STUDIES ON REGIONAL CEREBRAL CONTROL OF VOLUNTARY MOVEMENT
od: Brooks, D, i wsp.
Wydane: (1993)

Neuronal activity of the supplementary motor area (SMA) during internally and externally triggered wrist movements.
od: Thaler, D, i wsp.
Wydane: (1988)

Pedunculopontine nucleus stimulation improves akinesia in a Parkinsonian monkey.
od: Jenkinson, E, i wsp.
Wydane: (2004)

Apomorphine Penject – Emerging Evidence and Treatment Strategies for Delayed on and off Periods in Parkinson’s disease
od: Olivier Rascol, i wsp.
Wydane: (2014-07-01)

The role of the pedunculopontine region in basal-ganglia mechanisms of akinesia.
od: Munro-Davies, L, i wsp.
Wydane: (1999)